Compare MYGN & RNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYGN | RNGR |
|---|---|---|
| Founded | 1991 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.2M | 370.2M |
| IPO Year | 1996 | 2017 |
| Metric | MYGN | RNGR |
|---|---|---|
| Price | $3.05 | $17.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | $7.64 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 2.4M | 222.1K |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 6.81% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.12 |
| Revenue | ★ $771,400,000.00 | N/A |
| Revenue This Year | $6.86 | $23.86 |
| Revenue Next Year | $5.45 | $4.37 |
| P/E Ratio | ★ N/A | $144.33 |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $2.74 | $11.88 |
| 52 Week High | $8.59 | $18.82 |
| Indicator | MYGN | RNGR |
|---|---|---|
| Relative Strength Index (RSI) | 27.39 | 67.13 |
| Support Level | $2.74 | $16.02 |
| Resistance Level | $5.52 | $17.94 |
| Average True Range (ATR) | 0.25 | 0.54 |
| MACD | -0.11 | 0.19 |
| Stochastic Oscillator | 10.94 | 92.83 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Ranger Energy Services Inc offers high specification mobile rig well services, cased hole wireline services, and ancillary services in the U.S. oil and gas industry. Its services facilitate operations throughout the lifecycle of a well, including the completion, production, maintenance, intervention, workover, and abandonment phases. The company's reportable segments are: High Specification Rigs, Wireline Services, Processing Solutions and Ancillary Services. Maximum revenue is generated from the High Specification Rigs segment, which offers high specification well service rigs and complementary equipment and services to facilitate operations throughout the lifecycle of a well. The high specification rig services consist of well completion support, workovers, and well maintenance services.